Janux Therapeutics Inc (JANX)
59.86
+19.68
(+48.98%)
USD |
NASDAQ |
Dec 03, 16:00
60.39
+0.53
(+0.89%)
After-Hours: 19:59
Janux Therapeutics Price: 59.86 for Dec. 3, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Dec 03, 2024 | 67.17 | 71.25 | 59.30 | 59.86 | 7.669M |
| Dec 02, 2024 | 45.02 | 45.90 | 40.02 | 40.18 | 3.006M |
| Nov 29, 2024 | 46.13 | 46.92 | 45.18 | 45.21 | 534619.0 |
| Nov 27, 2024 | 48.10 | 49.69 | 46.30 | 46.39 | 650131.0 |
| Nov 26, 2024 | 48.82 | 49.74 | 47.70 | 48.00 | 457414.0 |
| Nov 25, 2024 | 51.08 | 52.38 | 48.40 | 48.82 | 1.213M |
| Nov 22, 2024 | 46.50 | 50.63 | 46.02 | 50.31 | 797810.0 |
| Nov 21, 2024 | 49.04 | 49.78 | 45.95 | 46.50 | 785995.0 |
| Nov 20, 2024 | 48.34 | 49.34 | 47.61 | 48.96 | 391494.0 |
| Nov 19, 2024 | 47.75 | 49.74 | 47.50 | 49.01 | 632330.0 |
| Nov 18, 2024 | 48.70 | 49.14 | 47.04 | 48.12 | 530206.0 |
| Nov 15, 2024 | 50.41 | 51.09 | 48.34 | 48.76 | 699105.0 |
| Nov 14, 2024 | 51.39 | 52.87 | 50.55 | 51.10 | 395039.0 |
| Nov 13, 2024 | 52.92 | 53.71 | 51.93 | 51.99 | 346972.0 |
| Nov 12, 2024 | 52.83 | 54.95 | 52.00 | 52.84 | 583641.0 |
| Nov 11, 2024 | 54.16 | 54.97 | 50.51 | 53.68 | 1.012M |
| Nov 08, 2024 | 54.81 | 55.97 | 53.60 | 53.92 | 844979.0 |
| Nov 07, 2024 | 55.91 | 56.50 | 53.54 | 54.21 | 706178.0 |
| Nov 06, 2024 | 56.54 | 57.48 | 54.40 | 54.89 | 1.020M |
| Nov 05, 2024 | 55.46 | 56.14 | 54.01 | 55.28 | 447310.0 |
| Nov 04, 2024 | 53.50 | 58.06 | 52.40 | 55.87 | 838699.0 |
| Nov 01, 2024 | 54.28 | 55.93 | 52.67 | 54.39 | 572929.0 |
| Oct 31, 2024 | 55.05 | 55.24 | 53.44 | 53.99 | 604782.0 |
| Oct 30, 2024 | 54.22 | 56.55 | 54.14 | 55.95 | 529503.0 |
| Oct 29, 2024 | 54.32 | 55.11 | 52.39 | 54.21 | 299973.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
5.85
Minimum
Nov 09 2023
64.78
Maximum
May 03 2024
22.24
Average
15.70
Median
Nov 16 2022
Price Benchmarks
| Dynavax Technologies Corp | 12.79 |
| Galectin Therapeutics Inc | 2.60 |
| Krystal Biotech Inc | 185.97 |
| Phathom Pharmaceuticals Inc | 8.84 |
| Poseida Therapeutics Inc | 9.33 |
Price Related Metrics
| PS Ratio | 234.92 |
| Price to Book Value | 4.788 |
| Earnings Yield | -1.94% |
| Market Cap | 3.142B |